NCIt definition : A preparation of autologous tumor infiltrating lymphocytes (TILs) gene-edited with
the clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 nuclease
complex to inactivate both the endogenous genes suppressor of cytokine signaling 1
(SOCS1) and Regnase-1, with potential immunomodulating and antineoplastic activities.
Upon infusion of the autologous CRISPR-Cas9 engineered Regnase-1/SOCS1 dual-edited
TILs KSQ-004EX back into the patient, the cells specifically recognize, target and
kill the patient's tumor cells. Inactivation of endogenous SOCS1 and Regnase-1 in
the TILs increases responsiveness to cytokine signals, increases persistence and memory
formation of TILs, and enhances anti-tumor responses.;
Molecule name : KSQ 004EX; KSQ 004; KSQ-004; KSQ-004EX;